Deb Cooperman

Deb Cooperman, 65, is a New Jersey resident who has been paying a high price for the weight-loss drug Zepbound. As she prepares for retirement, she is uncertain about her eligibility for the new Medicare Bridge program, which could significantly reduce her medication costs and improve her financial situation while continuing her weight-loss journey.